Calmodulin-related genes have been implicated in many cancers, and CALML3 was reported to be a potential biomarker for pulmonary metastasis of HCC20, while dysregulation of CALM1 in HCC was first observed in our previous study31. This evidence concerns the gene CALML3 and hepatocellular carcinoma.